DK131576B - Analogous process for the preparation of 6-halogen-substituted 4-oxa-androstanes. - Google Patents

Analogous process for the preparation of 6-halogen-substituted 4-oxa-androstanes.

Info

Publication number
DK131576B
DK131576B DK527668AA DK527668A DK131576B DK 131576 B DK131576 B DK 131576B DK 527668A A DK527668A A DK 527668AA DK 527668 A DK527668 A DK 527668A DK 131576 B DK131576 B DK 131576B
Authority
DK
Denmark
Prior art keywords
androstanes
oxa
halogen
substituted
preparation
Prior art date
Application number
DK527668AA
Other languages
Danish (da)
Other versions
DK131576C (en
Inventor
M R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK131576B publication Critical patent/DK131576B/en
Application granted granted Critical
Publication of DK131576C publication Critical patent/DK131576C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK527668A 1967-11-03 1968-10-30 ANALOGICAL PROCEDURE FOR PREPARING 6-HALOGEN-SUBSTITUTED 4-OXA ANDROSTANES DK131576C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
DK131576B true DK131576B (en) 1975-08-04
DK131576C DK131576C (en) 1976-01-05

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527668A DK131576C (en) 1967-11-03 1968-10-30 ANALOGICAL PROCEDURE FOR PREPARING 6-HALOGEN-SUBSTITUTED 4-OXA ANDROSTANES

Country Status (14)

Country Link
AT (2) AT297236B (en)
BE (1) BE723189A (en)
BR (1) BR6803654D0 (en)
CH (1) CH505855A (en)
DK (1) DK131576C (en)
ES (1) ES359842A1 (en)
FI (1) FI48098C (en)
FR (2) FR1605466A (en)
GB (1) GB1247022A (en)
IE (1) IE33567B1 (en)
IL (1) IL30879A (en)
NL (1) NL6815623A (en)
NO (1) NO132101C (en)
SE (1) SE352360B (en)

Also Published As

Publication number Publication date
ES359842A1 (en) 1970-06-16
NO132101B (en) 1975-06-09
BR6803654D0 (en) 1973-01-16
DE1805857A1 (en) 1969-06-26
FI48098B (en) 1974-02-28
SE352360B (en) 1972-12-27
IE33567B1 (en) 1974-08-21
FR8435M (en) 1971-07-15
BE723189A (en) 1969-04-30
FR1605466A (en) 1976-05-14
GB1247022A (en) 1971-09-22
NO132101C (en) 1975-09-17
IE33567L (en) 1969-05-03
AT297236B (en) 1972-03-10
NL6815623A (en) 1969-05-06
DE1805857B2 (en) 1977-06-23
DK131576C (en) 1976-01-05
FI48098C (en) 1974-06-10
AT287932B (en) 1971-02-10
IL30879A (en) 1972-11-28
IL30879A0 (en) 1968-12-26
CH505855A (en) 1971-04-15

Similar Documents

Publication Publication Date Title
DK137232B (en) Analogous process for the preparation of phenylethanolamines.
DK122222B (en) Process for the preparation of alk-3-en-1-ols.
DK133783B (en) Process for the preparation of 7-halo-7-deoxy-1-thio-alpha-D-galacto-octopyranosides.
DK120698B (en) Analogous process for the preparation of acetylguanidines.
DK124080B (en) Process for the preparation of D-6-methyl-8-cyanomethylergoline.
DK118820B (en) Analogous process for the preparation of derivatives of 5-nitro-2-furyl-isoxazolines.
DK123482B (en) Analogous process for the preparation of alkaloids.
DK119307B (en) Process for the preparation of ketonitriles.
DK124536B (en) Analogous process for the preparation of 4-aryl-3-hydroxybutyrohydroxamic acid.
DK123868B (en) Analogous process for the preparation of 3-hydroxycoumarin derivatives.
DK122758B (en) Process for the preparation of α-methyl-multicyclo-methylamines.
DK122522B (en) Process for the preparation of dichloroquinolines.
DK123100B (en) Process for the preparation of N-tritylimidazoles.
DK119663B (en) Analogous process for the preparation of 2-benzenesulfonamidopyrimidine compounds.
DK118507B (en) Process for the preparation of 3-dimethylsulfamoylphentiazine derivatives.
DK131821B (en) Analogous process for the preparation of a 2-carbalkoxyaminobenzimidazole.
DK118558B (en) Analogous process for the preparation of N-pyridylformimino ethers.
DK135287B (en) Analogous process for the preparation of styrylthiazolium salts.
DK119976B (en) Analogous process for the preparation of 18-methyl-19-nor-17α-hydroxyprogesterones and -17-esters thereof.
DK130307B (en) Process for the preparation of 3-oxo-13β-alkyl-17β-hydroxy-17α-ethynylgona-4,9-dienes.
DK117568B (en) Analogous process for the preparation of phthalazino-phthalazine dions.
DK122666B (en) Analogous process for the preparation of hydrocortisone-17-cyclopentanecarboxylate.
DK123476B (en) Process for the preparation of 3-oxo-A-nor-B-homo-estra-5 (10) -enes.
DK129842B (en) Process for the preparation of 3-imino-1,2-benzisothiazolines.
DK117900B (en) Analogous process for the preparation of 1-aminoacyl-quinazolin-4-ones.